Prescient Therapeutics Ltd
ASX:PTX

Watchlist Manager
Prescient Therapeutics Ltd Logo
Prescient Therapeutics Ltd
ASX:PTX
Watchlist
Price: 0.08 AUD -5.88% Market Closed
Market Cap: 84.1m AUD

Wall Street
Price Targets

PTX Price Targets Summary
Prescient Therapeutics Ltd

There are no price targets for PTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Prescient Therapeutics Ltd Competitors:
Price Targets
NTLA
Intellia Therapeutics Inc
134% Upside
7774
Japan Tissue Engineering Co Ltd
147% Upside
CANTA
Cantargia AB
96% Upside
BVXP
Bioventix PLC
121% Upside
MRSN
Mersana Therapeutics Inc
16% Upside
CRVO
Diffusion Pharmaceuticals Inc
183% Upside
ELDN
Eledon Pharmaceuticals Inc
410% Upside
688180
Shanghai Junshi Biosciences Co Ltd
24% Downside

Revenue
Forecast

Revenue Estimate
Prescient Therapeutics Ltd

For the last 13 years the compound annual growth rate for Prescient Therapeutics Ltd's revenue is 3%.

3%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Prescient Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Prescient Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PTX's stock price target?
Not Available

PTX doesn't have any price targets made by Wall Street professionals.

Back to Top